Dr. Reddy's divests non-core brands in dermatology to Eris Lifesciences for Rs 275 Cr
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Biocorp will receive an initial milestone payment this year
Proposed combination enhances Pfizer’s position as a leading company in oncology
The company will be submitting the responses to US FDA observations within stipulated timeline
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Subscribe To Our Newsletter & Stay Updated